The Leiden Mutation and Activated Protein C Resistance as Risk Factors for Disseminated Intravascular Coagulation in Acutely Poisoned Patients

REFERENCES

• Janiszewska M, Prazanowski M, Musialowicz E. Early diagnosis of disseminated intrarascular coagulation in the clinic of acute intoxications. Med Pr 1978; 29: 486–495, [CSA]
   Google Scholar
• Celvin BT. Management of disseminated intravascular coagulation. B J Heamatol 1998; 101(1)1517, [CSA]
   Google Scholar
• Aleksewicz P. Resistance to activated protein C as risk factor of venous thromboembolism. Acta Angiol 1997; 3: 49–51, [CSA]
   Google Scholar
• Cadroy J, Sié P, Boneu B. Frequency of the defective response to activated protein C in patients with a history of venous thrombosis. Letters to the Editor. Blood 1994; 94: 2008–2009, [CSA]
   Google Scholar
• Doggen CJM, Manger Cats V, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors. Increased risk of myocardial infraction associated with factor V Leiden and prothrombin 20210 A. Circulation 1998; 97: 1037, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Griffin JH, Eratt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1983–1993, [CSA]
   Google Scholar
• Kearon C, Crowther M, Hirsh J. Management of patients with hereditary disorders. Annual Review Med 2000; 51: 169–185, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Koelman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Blood 1994; 84: 1031–1035, [CSA]
   PubMed Web of Science ®Google Scholar
• Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C or protein S deficiency. Arterioscler Thromb Vasc Biol 1996; 16: 742–748, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens ChH, Lindpaintner K, Stampfer MJ, Elsenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently men. New Engl J Med 1995; 332: 912–917, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rosen SB, Sturk A. Activated protein C resistance—a major risk for thrombosis (Review). Env J Clin Chem Clin Biochem 1997; 35: 501–516, [CSA]
   PubMedGoogle Scholar
• Rosendaal FR, Koster T, Vandenbroncke JP, Reitsma PH. Hight risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504–1508, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. New Engl J Med 1994; 330: 517–522, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518–3529, [CSA]
   PubMed Web of Science ®Google Scholar
• Dahlbäck B. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism. J Int Med 1995; 237: 221–225, [CSA]
   PubMed Web of Science ®Google Scholar
• Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Diiven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–67, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jankowski M, Sanak M, Axenti I, Krzanowski M, Drapinski J, Nowakowski T, Brzostek T, Musial J, Tendera M, Szczeklik A. The phenomenon of inherited thrombophilia in atheroclerosis and venous thrombosis: factor V Leiden and prothrombin variant 20210A. Diagn Lab 1999; 35: 67–72, [CSA]
   Google Scholar
• Lewandowski K, Turoniecka Z, Ro0ek M, Markiewicz WT, Zawilska K. Frequency of the factor V gene Leiden mutation in patients with thromboembolic disease: analysis of 147 consecutive cases. Acta Haematol Pol 1997; 28: 31–37, [CSA]
   Google Scholar
• Lopaciuk S, Bykowska K. Prevalance of poor anticoagulant response to activated protein C in patients with a history of venous thrombosis. (Abstract) Haemostasis 1994; 24(1)141, [CSA]
   Google Scholar
• Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133–1134, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dahlbäck B, Carlsson M, Svenson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Nat Acad Sci 1993; 90: 1004–1008, [CSA]
   PubMed Web of Science ®Google Scholar
• Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521–2524, [CSA]
   PubMed Web of Science ®Google Scholar
• Engel H, Zwang L, van Vliet HHDM, Michiels JJ, Stibbe J, Lindermans J. Phenotyping and genotyping of coagulation factor V Leiden. Thromb Haemost 1996; 75: 267–269, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kraus M, Zander N, Fickenscher K. Coagulation assay with improved specificity to factor V mutants insensitive to activated protein C. Thromb Res 1995; 80: 255–264, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• De Ronde H, Bertino RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880–886, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Trossaert M, Conard J, Horelou MH, Elalarny I, Samama MM. La diagnostic biologique de la résistance á la protéine C activéé. Reve Franceses des laboratores 1995; 9: 19–23, [CSA], [CROSSREF]
   Google Scholar
• Watala C, Golanski J, Skrzypinska D, Chi0ynski K, Bienkiewicz A, Pietrucha T. Detection of thrombophilia associated with Leiden factor V mutation using selected diagnostic tests in patients with impaired anticoagulation. Diag Lab 1998; 34: 177–189, [CSA]
   Google Scholar
• Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thrombosis. Blood 1995; 85: 607–614, [CSA]
   PubMed Web of Science ®Google Scholar
• Koster T, Rosendaal F, de Ronde H, Briët E, Vadenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503–1506, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Leroy-Matheron C, Levent M, Pigon JM, Mendoca C, Gouault-Heilmann N. The 1691 G > A mutation in the factor V gene: relationship to activated protein C (APC) resistance and thrombosis in 65 patients. Thromb Haemostasis 1996; 75: 4–10, [CSA]
   PubMed Web of Science ®Google Scholar
• Kondaveeti S, Hibberd ML, Booy R, Nadel S, Levin M. Effect of the factor V Leiden mutation on the severity of meningococcal disease. Pediatr Infect Dis J 1999; 18: 893–896, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar